Cleveland BioLabs Valuation

Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Cleveland BioLabs prevailing Real Value cannot be determined due to lack of data. The current price of Cleveland BioLabs is $0.0. Our model approximates the value of Cleveland BioLabs from analyzing the firm fundamentals such as return on equity of -31.86, and Current Valuation of 66.46 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and trading away overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Cleveland BioLabs Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Cleveland BioLabs's current stock value. Our valuation model uses many indicators to compare Cleveland BioLabs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cleveland BioLabs competition to find correlations between indicators driving Cleveland BioLabs's intrinsic value. More Info.
Cleveland BioLabs is number one stock in price to book category among related companies. It is number one stock in beta category among related companies totaling about  0.13  of Beta per Price To Book. The ratio of Price To Book to Beta for Cleveland BioLabs is roughly  7.82 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cleveland BioLabs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cleveland BioLabs' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cleveland BioLabs' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cleveland BioLabs' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cleveland BioLabs and how it compares across the competition.

Cleveland BioLabs Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Cleveland BioLabs does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Shares Percent Shares Out0.19%
Float Shares7.69M
Shares Short Prior Month90.83k
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Cleveland Stock

If you are still planning to invest in Cleveland BioLabs check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cleveland BioLabs' history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Transaction History
View history of all your transactions and understand their impact on performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios